Is there anybody here that undergoes the research treatment NCT07258511 concerning 1 arm with JNJ-79635322 and 1 arm with anti-BCMxCD3?
This is a research treatment with antibodies. JNJ-79635322 is trispecific and the anti-BCMxCD3 is bispecific.
Do you encounter side effects and if yes how bad are they?
I have 27 IgA, 2100 IgG and 31 IgM, what does that mean?
IsIgM high or low in myeloma?
Is there a specific number to differentiate between myeloma and MGUS?